Neuromuscular Electrical Stimulation
Devicequadriceps strenghthening with neuromuscular electrical stimulation (medical device)
NCT Number: NCT02656667
The aim of this study is to evaluate the effectiveness of quadriceps strengthening with neuromuscular electrical stimulation versus cycle ergometer as part of pulmonary rehabilitation program , in patients with severe or very severe COPD , according to GOLD with BODE index ≥ 5 .
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Centre des maladies respiratoires et allergiques - Les Acacias, Briançon, France
It's a prospective ,multicentre,randomised, single-blind study which compare the effectiveness of quadriceps strengthening with neuromuscular electrical stimulation versus cycle ergometer training as part of pulmonary rehabilitation program.
The program lasts from 3 to 4 weeks. 102 patients will included, diagnosed with COPD stages GOLD III and IV, and BODE index ≥ 5.
The commun program: training protocol performed on treadmill,quadriceps resistance training,patient therapeutic education,collective gymnastics,relaxation, session psychological care, smoking cessation program and nutritional management if necessary.
The primary criterion is the one minute sit to stand test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
quadriceps strenghthening with neuromuscular electrical stimulation (medical device)
quadriceps strenghthening with cycle ergometer training
excercise training on treadmill
Time frame: 21 - 4 days / +7 days
Measure of the functional capacity of the lower limb muscles with the "1 minute Sit To Stand Test "
Time frame: 21 - 4 days / +7 days
Quadriceps strength assessment with handheld dynamometer
Time frame: 21 - 4 days / +7 days
Measure of isometric voluntary quadriceps endurance assessment with handheld dynamometer
Time frame: 21 - 4 days / +7 days
Six minute walking test for assessing exercise capacity
Time frame: 21 - 4 days / +7 days
COPD assessment test for assessing quality of life
Time frame: 21 - 4 days / +7 days
Measure of dyspnea with Borg scale at the end of the six minute walking test
Time frame: 21 - 4 days / +7 days
Measure of dyspnea with Medical Research Council Dyspnea Scale
Time frame: 21 - 4 days / +7 days
Measure of dyspnea with Dyspnea 12 questionnary
Time frame: 21 - 4 days / +7 days
Measure of inspiratory capacity (in litres) by spirometry
University Hospital, Brest
Other
Acronym: ESNM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details